Kiromic Stock Analysis

KRBP -  USA Stock  

USD 2.86  0.26  8.33%

Our technical analysis module lets you check existing technical drivers of Kiromic Biopharma as well as the relationship between them. The company directors and management failed to add value to investors and positioning the firm supply of money to exploit market volatility in June. However, diversifying your holdings with Kiromic Biopharma or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 8.2. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Kiromic Biopharma partners.
Please see Stocks Correlation.

Search Stock Analysis 

 
Refresh
The Kiromic Biopharma stock analysis report makes it easy to digest most publicly released information about Kiromic Biopharma and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Kiromic Stock analysis module also helps to analyze the Kiromic Biopharma price relationship with some important fundamental indicators such as market cap and management efficiency.

Kiromic Stock Analysis Notes

The company had not issued any dividends in recent years.

Kiromic Biopharma Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Kiromic Biopharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Kiromic Biopharma or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Kiromic Biopharma generates negative expected return over the last 90 days
Kiromic Biopharma has high historical volatility and very poor performance
Latest headline from MacroaxisInsider: Kiromic Biopharma exotic insider transaction detected

Management Efficiency

Kiromic Biopharma management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 28th of July, Kiromic Biopharma secures the risk adjusted performance of (0.15), and Mean Deviation of 3.86. Our technical analysis interface lets you check existing technical drivers of Kiromic Biopharma, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We have analyzed nineteen technical drivers for Kiromic Biopharma, which can be compared to its peers in the industry. Please verify Kiromic Biopharma variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Kiromic Biopharma is priced some-what accurately, providing market reflects its recent price of 2.86 per share. Please also check out Kiromic Biopharma total risk alpha, which is currently at (1.75) to check the company can sustain itself at a future point.

Kiromic Biopharma Price Movement Analysis

Study
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Instantaneous Trendline is a moving-average-like indicator which is formed by removing the Dominant Cycle from Kiromic Biopharma price series. View also all equity analysis or get more info about hilbert transform instantaneous trendline overlap studies indicator.

Kiromic Biopharma Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Kiromic Biopharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Kiromic Biopharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Kiromic Biopharma insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Kiromic Biopharma Technical and Predictive Indicators

Kiromic Biopharma Forecast Models

Kiromic Biopharma time-series forecasting models is one of many Kiromic Biopharma's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Kiromic Biopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Kiromic Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Kiromic Biopharma stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Kiromic shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Kiromic Biopharma. By using and applying Kiromic Stock analysis, traders can create a robust methodology for identifying Kiromic entry and exit points for their positions.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Kiromic Biopharma to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Focused Opportunities Now

   

Focused Opportunities

Build portfolios using our predefined set of ideas and optimize them against your investing preferences
All  Next Launch Module
Please see Stocks Correlation. Note that the Kiromic Biopharma information on this page should be used as a complementary analysis to other Kiromic Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Kiromic Stock analysis

When running Kiromic Biopharma price analysis, check to measure Kiromic Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiromic Biopharma is operating at the current time. Most of Kiromic Biopharma's value examination focuses on studying past and present price action to predict the probability of Kiromic Biopharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kiromic Biopharma's price. Additionally, you may evaluate how the addition of Kiromic Biopharma to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
The market value of Kiromic Biopharma is measured differently than its book value, which is the value of Kiromic that is recorded on the company's balance sheet. Investors also form their own opinion of Kiromic Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Kiromic Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kiromic Biopharma's market value can be influenced by many factors that don't directly affect Kiromic Biopharma underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kiromic Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Kiromic Biopharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kiromic Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.